Our study described the global metabolic profile of PV patients, analyzed the metabolites associated with JAK2 mutations and their relationship with blood cell counts, and screened metabolites associated with the prognosis of PV patients by risk stratification, providing new insights into the pathogenesis of PV and a reference for assessing patient prognosis. This evidence concerns the gene JAK2 and acquired polycythemia vera.